Filing Flows › Puma Biotechnology (PBYI) › Product revenue
Puma Biotechnology (PBYI) Product revenue by quarter
Puma Biotechnology's Product revenue was $54.1M in Q3 2026 (third quarter 2026), +1% from Q2 2026. Over the last 7 quarters it ranged from $42.0M (Q1 2026) to $59.9M (Q4 2025).
| Quarter | Product revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $54.1M | +1% | +4% |
| Q2 2026 | $53.6M | +28% | +9% |
| Q1 2026 | $42.0M | -30% | -3% |
| Q4 2025 | $59.9M | +15% | — |
| Q3 2025 | $51.9M | +6% | — |
| Q2 2025 | $49.2M | +14% | — |
| Q1 2025 | $43.1M | — | — |
Q3 2026 at a glance
Puma Biotechnology, Q3 2026: revenue $55.1M (+1% year over year), operating margin 9.6%, net earnings $6.0M, operating cash flow $14.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Puma Biotechnology's Product revenue?
Puma Biotechnology's Product revenue was $54.1M in Q3 2026 (third quarter 2026), +1% from Q2 2026.
How has Puma Biotechnology's Product revenue changed?
Over the last 7 quarters it ranged from $42.0M (Q1 2026) to $59.9M (Q4 2025).